Tag: NHS 2025 reforms

UK Substitution Laws: How NHS Policies Are Changing Generic Medicines and Care Delivery

UK Substitution Laws: How NHS Policies Are Changing Generic Medicines and Care Delivery

UK substitution laws are reshaping how the NHS delivers medicines and care, pushing generics and remote services to cut costs. But without enough staff and support, these changes risk leaving vulnerable patients behind.

RECENT POSTS

April 30, 2023
The Link Between High Eye Pressure and Glaucoma: What You Need to Know

In a recent blog post, I discussed the link between high eye pressure and glaucoma, a potentially blinding eye disease. I learned that high eye pressure, also known as ocular hypertension, can damage the optic nerve and lead to glaucoma. It's important to have regular eye exams to detect any changes in eye pressure early on. While not everyone with high eye pressure will develop glaucoma, it is still a significant risk factor. Therefore, it's essential to be proactive in managing eye pressure and maintaining overall eye health.

November 19, 2025
Insurance Coverage of Generic Combinations vs Individual Generics: What You Really Pay

Insurance plans often cover generic combination drugs differently than individual generics, leading to confusing and sometimes costly outcomes. Learn how formularies, tiers, and pricing affect your out-of-pocket costs-and how to save money.

December 17, 2025
Affirmative Consent Laws: How Patient Permission for Medical Substitution Actually Works

Affirmative consent laws don't apply to medical decisions. Learn how real patient permission works through informed consent and substituted judgment when you can't speak for yourself.

July 9, 2025
Buy Prescription Medicine Safely: Guide to Using OnlinePillsWWW.com

Learn how OnlinePillsWWW.com is changing the way people buy prescription drugs online. Get tips for safety, legal info, and how to spot legit pharmacies.

December 21, 2025
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025

Learn how the FDA's 2025 update to biosimilar approval rules is accelerating access to lower-cost biologic alternatives, why they're not the same as generics, and what this means for patients and providers.